MedPath

Synthetic THC And Blood Pressure

Not Applicable
Not yet recruiting
Conditions
Blood Pressure
Interventions
Drug: Placebo
Registration Number
NCT07231965
Lead Sponsor
Mayo Clinic
Brief Summary

To investigate the effects of Dronabinol use on blood pressure and neurovascular physiology

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Dronabinol GroupDronabinolPatients taking Dronabinol first and Placebo second
Dronabinol GroupPlaceboPatients taking Dronabinol first and Placebo second
Placebo GroupDronabinolPatients taking Placebo first and Dronabinol second
Placebo GroupPlaceboPatients taking Placebo first and Dronabinol second
Primary Outcome Measures
NameTimeMethod
Blood PressureBaseline, 30 days

Blood pressure is the force exerted by circulating blood on the walls of the arteries as it is pumped through the body. Blood pressure will be measured as a ratio of systolic/diastolic (mmHg).

Heart RateBaseline, 30 days

Heart Rate is the number of contractions (beats) that the heart makes per minute. This will be measured in bpm (beats per minute)

Secondary Outcome Measures
NameTimeMethod
Flow Mediated DilationBaseline, 30 days

Flow Mediated Dilation will be measured by ultrasonography of brachial artery, reported as an absolute change in arterial diameter from resting baseline

Aortic Wave ReflectionBaseline, 30 days

Aortic Wave Reflection will be measured via arterial tonometry, reported as aortic augmentation index

Baroreflex SensitivityBaseline, 30 days

Baroreflex sensitivity will be assessed using beat-by-beat blood pressure, heart rate, and Sympathetic nerve activity collected continuously for at least 5min. This will be measured in ms/mmHg.

Sympathetic controlBaseline, 30 days

Sympathetic control will be measured by microneurography of peroneal or fibular nerve, reported as bursts of sympathetic activity per minute or normalized to 100 heart beats

Trial Locations

Locations (1)

Mayo Clinic in Rochester

🇺🇸

Rochester, Minnesota, United States

Mayo Clinic in Rochester
🇺🇸Rochester, Minnesota, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.